Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation

BACKGROUND: Dabigatran is associated with lower rate of stroke comparing to warfarin when anticoagulation control is sub-optimal. Genotype-guided warfarin dosing and management may improve patient-time in target range (TTR) and therefore affect the cost-effectiveness of dabigatran compared with warf...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Joyce H. S., Tsui, Kia K. N., Wong, Raymond S. M., Cheng, Gergory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382133/
https://www.ncbi.nlm.nih.gov/pubmed/22745801
http://dx.doi.org/10.1371/journal.pone.0039640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382133/
https://www.ncbi.nlm.nih.gov/pubmed/22745801
http://dx.doi.org/10.1371/journal.pone.0039640

Ejemplares similares